Alfie from United Kingdom

Registered at the short selling broker Capital, 4 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Novartis AG (NVS) shares information

Novartis AG – ADR


24h Change

-0.13 %

NVS

Live rate: Market closed

Stock data per Monday 2 Aug, 2021

NVS
NEW YORK STOCK EXCHANGE, INC.
92.39
92.45
92.27
-0.12 (-0.13%)
US Market is closed

Live Stock price in graph for Novartis AG – ADR (NVS)

  • Latest Volume

    1,868,146 (34.76 %)

  • Volume prev. day

    1,386,324

  • Avg. daily volume

    1,655,438

  • Market cap

    224,624,018,288

  • P/E ratio

    23.42

  • Today high

    92.56 USD

  • Today low

    92.08 USD

  • 52 week high

    94.77 USD

  • 52 week low

    74.07 USD

  • YTD Change

    + 1.64 %

Quick links

 

Latest news about Novartis AG – ADR

Below you can find the most recent news posts about Novartis AG – ADR, primarily from US and UK based news sources.

Lipid Metabolism Disease Treatment Market to 2028 – Trend Forecast and Growth Opportunities | Merck Group, Novartis, AstraZeneca, KOWA, Kythera, Fuji yakuhin

Monday, 2 August 2021, 22:42:19
Lipids are not only storage of body energy; they involve in preserving and regulating cell function. The disruption of lipid metabolic enzymes and pathways occurs in many diseases such as cancer, diabetes, infectious, neurodegenerative, and inflammatory diseases. Researchers developed several
— OpenPR


Global Cellulitis Antibiotics Market Size, Trends and Forecast 2027 By | Sun Pharmaceutical Industries Ltd, Dr. Reddys Laboratories Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG

Monday, 2 August 2021, 20:10:09
Cellulitis is a type of skin infection caused by bacteria, most commonly streptococcus and staphylococcus. Streptococcus sp. and staphylococcus sp. can infect any part of the body; however, streptococcus sp. and staphylococcus sp. are most commonly seen in the lower
— OpenPR


Drug Discovery Technologies Market is ready for its next Big Move | Bayer Healthcare, Novartis, AstraZeneca, Affymetrix

Monday, 2 August 2021, 16:54:00
The Drug Discovery Technologies market research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, []
— iCrowdNewswire


Type I Hyperlipoproteinemia Drug Market New Study Offers Insights for 2027 | Novartis AG, Aegerion Pharmaceuticals Inc.

Monday, 2 August 2021, 16:39:57
This Type I Hyperlipoproteinemia Drug market report also includes a segment-by-segment examination of macroeconomics factors, controlling variables, and parent market conditions, as well as competitive intensity. This outstanding Type I Hyperlipoproteinemia Drug market report accurately depicts the entire market environment.
— OpenPR


Hydroxychloroquine Market 2021-2027 | To Reach USD 2,339.1 Million by 2027, Exhibit a CAGR of 5.5%

Monday, 2 August 2021, 14:20:00
Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG
— Intrado Digital Media


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have NVS available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.